Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K
Blood Transfusion01:15

Blood Transfusion

802
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
802
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Tissue Transplantation01:24

Tissue Transplantation

519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 心血管医学和血液学
  5. 血液学
  6. 在输血依赖β- 沙拉西米亚患者的健康相关生活质量改善后exagamglogene

在输血依赖β- 沙拉西米亚患者的健康相关生活质量改善后Exagamglogene

Josu de la Fuente1, Haydar Frangoul2, Peter Lang3

  • 1IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom.

Blood advances
|August 27, 2025

相关实验视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.5K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

在PubMed 上查看摘要

概括
此摘要是机器生成的。

在依赖输血的β- thalassemia的成人和青少年中,exagamglogene autotemcel (exa- cel) 基因疗法显著改善了与健康有关的生活质量,显示出持久且具有临床意义的益处.

科学领域:

  • 血液学
  • 基因治疗
  • 患者报告的结果

背景情况:

相关实验视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.5K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
  • 输血依赖性β- thalassemia (TDT) 对患者的健康相关生活质量 (HRQoL) 有不利影响.
  • 埃克萨基因自动治疗 (exa- cel) 是一种 ex vivo CRISPR- Cas9 基因编辑的细胞疗法.
  • 临床试验显示,exa- cel可导致大多数TDT患者的输血独立性.

研究的目的:

  • 评估exa-cel对TDT成人和青少年患者报告结果 (PRO) 的影响.
  • 在至少16个月的随访期内评估exacel输液后HRQoL的变化.

主要方法:

  • 在成年人中,PRO测量包括EQ-5D-5L和FACT-BMT,在青少年中则包括EQ-5D-Y和PedsQL.
  • 收集了54名参与者 (35名成年人,19名青少年) 的数据.
  • 纵向分析评估了从基线到48个月的HRQoL得分的变化.

主要成果:

  • 在48个月内,成年人在EQ- 5D- 5L VAS,美国/ 英国健康效用评分和FACT- G/ BMTS评分中显示出统计学意义上的和临床意义上的改善.
  • 在24个月后,青少年的EQ-5D- Y VAS和PedsQL总分,包括身体和心理健康,持续改善.
  • 在成人和青少年群体中,HRQoL的改善超过了临床重要的最小差异 (MCID).

结论:

  • 在TDT患者中,Exacel治疗导致了广泛,持久且具有临床意义的HRQoL改善.
  • 基因疗法除了可以独立于输血之外, 还有很大的好处,
  • 这些发现支持exa- cel作为转换性治疗输血依赖β- 血症的选择.